Get the latest news on HTG Molecular Diagnostics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on HTGMQ performance

Latest HTG Molecular Diagnostics Stock News | OTC:HTGMQ | Benzinga

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG MOLECULAR DGNSTCS INC by HTG Molecular Diagnostics, Inc.

Comments

HTG Molecular Diagnostics Stock News

News

Latest HTG Molecular Diagnostics Stock News | OTC:HTGMQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga